Positive data for Pfizer/BioNTech Covid-19 vaccine

Country

Germany

BioNTech SE and its partner Pfizer Inc, have announced positive interim Phase 3 data for their Covid-19 vaccine which is based on messenger RNA (mRNA) technology. The vaccine candidate was found to be more than 90% effective in preventing Covid-19 in participants without evidence of prior SARS-CoV-2 infection, the companies announced on 9 November.